155 related articles for article (PubMed ID: 29956808)
1. Inhibition of RAD54B suppresses proliferation and promotes apoptosis in hepatoma cells.
Wang R; Li Y; Chen Y; Wang L; Wu Q; Guo Y; Li Y; Liu J; Wang L
Oncol Rep; 2018 Sep; 40(3):1233-1242. PubMed ID: 29956808
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
3. RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer.
Zhang Z; Li X; Han Y; Ji T; Huang X; Gao Q; Ma D
Biomed Pharmacother; 2019 Oct; 118():109341. PubMed ID: 31545289
[TBL] [Abstract][Full Text] [Related]
4. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
5. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3.
Zhang J; Huang JZ; Zhang YQ; Zhang X; Zhao LY; Li CG; Zhou YF; Wei H; Yu J
EBioMedicine; 2020 Mar; 53():102701. PubMed ID: 32151798
[TBL] [Abstract][Full Text] [Related]
6. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
7. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.
Xu L; Dai W; Li J; He L; Wang F; Xia Y; Chen K; Li S; Liu T; Lu J; Zhou Y; Wang Y; Guo C
Oncotarget; 2016 May; 7(18):26027-41. PubMed ID: 27029030
[TBL] [Abstract][Full Text] [Related]
8. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
Zhu Y; Zhou C; He Q
J Int Med Res; 2019 Jan; 47(1):383-390. PubMed ID: 30394818
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of RAD54B expression reduces cell proliferation and induces apoptosis in lung cancer cells.
Xu C; Liu D; Mei H; Hu J; Luo M
J Int Med Res; 2019 Nov; 47(11):5650-5659. PubMed ID: 31558081
[TBL] [Abstract][Full Text] [Related]
10. Integrated study of miR-215 promoting breast cancer cell apoptosis by targeting RAD54B.
Wang M; Liao J; Tan C; Zhou H; Wang J; Wang K; Li Y; Wu W
J Cell Mol Med; 2021 Apr; 25(7):3327-3338. PubMed ID: 33635591
[TBL] [Abstract][Full Text] [Related]
11. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
12. Rad54B targeting to DNA double-strand break repair sites requires complex formation with S100A11.
Murzik U; Hemmerich P; Weidtkamp-Peters S; Ulbricht T; Bussen W; Hentschel J; von Eggeling F; Melle C
Mol Biol Cell; 2008 Jul; 19(7):2926-35. PubMed ID: 18463164
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of RRS1 by lentiviral-mediated RNAi promotes apoptosis and suppresses proliferation of human hepatocellular carcinoma cells.
Wang J; Li Z; Zuo C; Xie Q; Li H; Jia J; Zhen Z; Qi R; Li Z; Liu D; Sun B
Oncol Rep; 2017 Oct; 38(4):2166-2172. PubMed ID: 28849112
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
15. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
[TBL] [Abstract][Full Text] [Related]
16. Involvement of hepatopoietin Cn in the development of human hepatocellular carcinoma.
Zhu BD; Li XL; Liu Y; Chang J; Liu Y; Zhang DD; Wang Q; Ren J; Cui CP
Clin Exp Metastasis; 2010 Dec; 27(8):571-80. PubMed ID: 20683644
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
19. Silencing of the
Zhang J; Ma H; Yang L; Yang H; He Z
J Int Med Res; 2019 Mar; 47(3):1319-1329. PubMed ID: 30678511
[TBL] [Abstract][Full Text] [Related]
20. Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma.
Li N; Jiang S; Fu R; Lv J; Yao J; Mai J; Hua X; Chen H; Liu J; Lu M
Biomark Med; 2021 Apr; 15(5):347-358. PubMed ID: 33666519
[No Abstract] [Full Text] [Related]
[Next] [New Search]